TW377295B - Stnthetic peptides specific for detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
- Google Patents
Stnthetic peptides specific for detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/558,799external-prioritypatent/US5106726A/en
Application filed by United Biomedical IncfiledCriticalUnited Biomedical Inc
Application grantedgrantedCritical
Publication of TW377295BpublicationCriticalpatent/TW377295B/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
The present invention relates to the application of a synthetic peptides for the detection of antibodies to HCV (the so-called NANBHV) and diagnosis of NANBH. Each of these peptides has an amino acid order qualifying the immune dominant region having protein and a non-structural multi-peptides, SOD/HCV C-100 and a hypothetic HCV structural (core) protein. This invention even applies a set of synthetic peptides in a specific order or the like for the detection of the HCV antibodies in the human secretion. The detection method includes ELISA and other immune tests. This invention relates also the method of application of these synthetic peptides, the like or the mixture in healthy mammals, including humans for the creation of an HCV antibody of high titration. By using a free, compound or polymerization of the synthetic peptides, synthetic vaccines are made of key compositions for fighting NANBH.
TW079108027A1990-07-261990-09-24Stnthetic peptides specific for detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
TW377295B
(en)